Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-28 @ 6:55 PM
Study NCT ID:
NCT05405868
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2022-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial
Sponsor:
University College, London
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-25
First Submit QC Date:
None
Study First Post Date:
2022-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-07
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL